Novel Post-Surgical Incision Management to Prevent Ostomy Complications
Recruiting now · Not applicable
Conditions studied: Ostomy, Enterocutaneous Fistula
In brief
The goal of this clinical trial is to evaluate the safety and effectiveness of the Limpet, as compared to standard of care ostomy pouches, in reducing complications for ostomy and fistula patients. Secondary objectives include evaluating dressing leak rates and causes of complications (e.g., edema, tissue oxygen saturation, and poor stoma eversion). The main questions it aims to answer are: Primary Hypothesis 1: Peristomal Skin Complications will decrease Primary Hypothesis 2: Dressing Leak Rates will decrease Participants will: * Receive either the Limpet device or standard of care adhesive ostomy pouch dressing * Return every 7 days for study visits for 30 days to receive device replacement, wound imaging, blood tests, and quality of life surveys.
Key facts
- Study ID
- NCT06524401
- Run by
- HealthPartners Institute
- People needed
- 92
- Starts
- 2024-11-18
- Expected to finish
- 2029-03-01
- Last updated by the study team
- 2025-09-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participant is greater than 18 years of age, inclusive
- Participant is undergoing ileostomy surgery or,
- has an enterocutaneous fistula with output over 500cc in 24 hours
- Participants stoma will have a maximum diameter of 1.5 inches based on measurements from the Investigator or Sponsor.
- Area around the stoma must have no injury through the dermis (i.e., intact skin)
- Participant is willing and able to comply with all protocol-specified requirements
- Participant is capable of reading and understanding English and will provide written informed consent to participate.
You may not qualify if…
- Unable/unwilling to attend the follow-up appointments
- Participant has a life expectancy < 30 days.
- Participant has a stature too small for use of the Limpet in the opinion of the Investigator or Sponsor.
- Participant has an enteroatmospheric fistula (enteric fistula to an open wound)
- Participant is scheduling/planning concurrent chemotherapy or other radiation treatment during the study follow-up period
- Participant has a history of sensitivity or allergy to hydrocolloids or other materials in the Limpet device.
- Participant is pregnant or planning to become pregnant (verbal report).
- Participant is unable or unwilling to provide informed consent.
- Participant is currently participating in an investigational drug or another device study that clinically interferes with the current study endpoints.
- Participant has any other disease or medical condition that, in the opinion of the Investigator or Sponsor, could endanger the participant, interfere with the evaluation of the study device's efficacy or safety, or compromise the participant's ability to comply with/complete the study.
Where it is running
- Regions Hospital — Saint Paul, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.